Julia Glade Bender

Julia Glade Bender

Memorial Sloan Kettering Cancer Center - Indore / United States
Medical and Health Sciences / Pediatric Hematology
AD Scientific Index ID: 4441298
person_outline Julia Glade Bender's MOST POPULAR ARTICLES
1-) Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of …B Geoerger, HJ Kang, M Yalon-Oren, LV Marshall, C Vezina, A Pappo, ...The Lancet Oncology 21 (1), 121-133, 20202732020
2-) Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children’s Oncology Group StudyJL Glade Bender, PC Adamson, JM Reid, L Xu, S Baruchel, Y Shaked, ...J Clin Oncol 26 (3), 399-405, 20082722008
3-) Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trialR Mody, A Naranjo, C Van Ryn, LY Alice, WB London, BL Shulkin, ...The lancet oncology 18 (7), 946-957, 20172582017
4-) VEGF blocking therapy in the treatment of cancerJ Glade-Bender, JJ Kandel, DJ YamashiroExpert opinion on biological therapy 3 (2), 263-276, 20032572003
5-) Multicenter feasibility study of tumor molecular profiling to inform therapeutic decisions in advanced pediatric solid tumors: the individualized cancer therapy (iCat) studyMH Harris, SG DuBois, JLG Bender, AR Kim, BD Crompton, E Parker, ...JAMA oncology 2 (5), 608-615, 20162192016